[Intravenous infusion of angiotensin for the diagnosis of arterial hypertension (Kaplan-Silah test)]. 1969

H Janukowicz-Lorenz, and J Lorenz, and K Skóra

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012078 Renal Artery Obstruction Narrowing or occlusion of the RENAL ARTERY or arteries. It is due usually to ATHEROSCLEROSIS; FIBROMUSCULAR DYSPLASIA; THROMBOSIS; EMBOLISM, or external pressure. The reduced renal perfusion can lead to renovascular hypertension (HYPERTENSION, RENOVASCULAR). Renal Artery Stenosis,Obstruction, Renal Artery,Obstructions, Renal Artery,Renal Artery Obstructions,Renal Artery Stenoses,Stenoses, Renal Artery,Stenosis, Renal Artery
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine

Related Publications

H Janukowicz-Lorenz, and J Lorenz, and K Skóra
April 1968, Il Policlinico. Sezione pratica,
H Janukowicz-Lorenz, and J Lorenz, and K Skóra
December 1965, Minerva medica,
H Janukowicz-Lorenz, and J Lorenz, and K Skóra
February 1970, Polski tygodnik lekarski (Warsaw, Poland : 1960),
H Janukowicz-Lorenz, and J Lorenz, and K Skóra
December 1969, Polski tygodnik lekarski (Warsaw, Poland : 1960),
H Janukowicz-Lorenz, and J Lorenz, and K Skóra
January 1967, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
H Janukowicz-Lorenz, and J Lorenz, and K Skóra
August 1966, Recenti progressi in medicina,
H Janukowicz-Lorenz, and J Lorenz, and K Skóra
June 1970, Wiadomosci lekarskie (Warsaw, Poland : 1960),
H Janukowicz-Lorenz, and J Lorenz, and K Skóra
January 1968, Deutsche medizinische Wochenschrift (1946),
H Janukowicz-Lorenz, and J Lorenz, and K Skóra
October 1969, Polskie Archiwum Medycyny Wewnetrznej,
H Janukowicz-Lorenz, and J Lorenz, and K Skóra
September 1966, Acta medica Scandinavica,
Copied contents to your clipboard!